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Abstract
Interstitial cystitis (IC), or painful bladder syndrome, is
an autoimmune condition with an unknown
etiology. Common symptoms include urinary
urgency, frequency, and bladder and urethral pain
and burning. This condition, like many autoimmune
disorders, disproportionately affects females;
therefore, female sex hormones are hypothesized to
play a role in the disorder. My hypothesis is that
estrogen, both endogenous and synthetic, affects the
severity of IC symptoms. Through surveying the
available literature on interstitial cystitis, I have found
that IC symptoms often correlate with low
estrogen. My hope is that by understanding more
about how hormones affect IC, we can come up with
better treatment plans for IC sufferers.

Introduction
Interstitial cystitis (IC) is a painful autoimmune
disorder characterized by urinary urgency,
frequency, and burning, along with bladder
pain. IC is recognized as a disability under the
Americans with Disabilities Act, and an
estimated 50% of IC sufferers are unable to
work due to their pain.
The cause of IC remains unknown, and
currently, there is only one drug, Elmiron, which
has been approved by the FDA to treat this
disorder. Elmiron is hypothesized to work by
coating the bladder lining, though its
mechanism of action is unknown. However,
Elmiron can interfere with liver function, cause
hair loss, and lead to internal bleeding.
Because of these side effects, and because
Elmiron does not work for everyone, many
patients are seeking alternative treatment
methods.

Methods
Literature survey was conducted using Google
Scholar. Search terms were “interstitial cystitis” and
“estrogen”, and “estrogen” and “autoimmunity”. The
dates of the referenced publications ranged from
2007 to 2015.

He, Q., Yang, Y., Xia, M., Li, G. Z., Zhang, N., Wu, S. L., ...
& Shen, H. (2015). Sex differences in risk factors for
interstitial cystitis/painful bladder syndrome in patients of
lower urinary tract symptoms in China. Surgical Practice.

Results
Table 1. Low estrogen is likely to play a role in
interstitial cystitis. The perimenstrual phase of the
menstrual cyde, as seen in Figure 1, which is
characterized by low estrogen correlates with the
highest prevalence of IC pain. In addition, mice who
lacked an estrogen receptor developed a phenotype
resembling IC, implying that estrogen signaling is
required for normal bladder homeostasis.
Reference
He. et al., 2015
Yamamoto et al., 2015

Powell-Boone et al., 2007

Imamov et al., 2007

Findings
Estrogen is likely to play a role
in interstitial cystitis
An increase in interstitial
cystitis symptoms is associated
with the perimenstrual phase of
the menstrual cycle.
The perimenstrual phase of the
menstrual cycle is associated
with the highest amount of
interstitial cystitis pain.
Female mice who were
deficient in estrogen receptor β
developed a bladder
phenotype resembling human
interstitial cystitis.

Table 2. Estrogen plays various roles within the
immune system, depending upon its
concentration, the estrogen receptor type
expressed by the immune cell in question, and
the type of immune cell.
Reference

Immune Cell Estrogen’s Effect
Type
Concentration-dependent;
Tan. et al., 2015 Th1, Treg
stimulated Th1 cells at low
concentration and Treg cells at
high concentrations
Increases migration of Th17
Andersson et al., Th17
cells to lymph nodes during
2015
early stages of autoimmune
arthritis, but decreases
migration of Th17 cells to joints
during the later stages of the
disease.
Laffont and
Dendritic
Estrogen activates dendritic
Guéry , 2015
Cells
cells.
Muñoz-Cruz et
Mast cells
Estrogen caused histamine
al., 2015
release from mast cells of
female rats, but not male rats.

Conclusions
• The relationship between estrogen and
the immune system is highly complex.
• The correlation between IC symptoms
and the perimenstrual phase of the
menstrual cycle suggest that using a form
of birth control which uses a constant
level of estrogen and skips the menstrual
phase may provide symptom relief.
Anecdotal evidence from the #icstrong
support group suggest that some women
are already doing this, and find it helpful
in alleviating their IC symptoms.

Symptoms of IC can often be ameliorated by
following a strict elimination diet. However, this
is not always effective. As a result, many IC
patients are treated using narcoticsl, vaginal
valium, or antidepressants.
Since many women report a worsening of IC
symptoms that correlates with the onset of their
menstrual period, it is my hypothesis that IC
symptoms correlate with low blood estrogen
levels.
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